A carregar...
Treg cells, cancer vaccines: timing is everything
In the current issue of Blood, Litzinger and colleagues demonstrate the critical role of proper timing of the denileukin diftitox (ONTAK) treatment for its ability to boost the immunologic activity of cancer vaccines.
Na minha lista:
| Autor principal: | |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
American Society of Hematology
2007
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2200914/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2007-07-102921 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|